Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 43 | 47 | 20 | 6 | 13 |
| Cost of Goods | 27 | 30 | 39 | 4 | 6 |
| Gross Profit | 16 | 17 | -19 | 2 | 7 |
| Operating Expenses | 1,899 | 2,023 | 1,882 | 1,902 | 1,890 |
| Operating Income | -1,856 | -1,975 | -1,862 | -1,896 | -1,877 |
| Interest Expense | 0 | 1 | 2 | 0 | 1 |
| Other Income | 0 | 0 | 1 | 1 | 2 |
| Pre-tax Income | -1,856 | -1,976 | -1,863 | -1,895 | -1,875 |
| Net Income Continuous | -1,856 | -1,976 | -1,863 | -1,895 | -1,875 |
| Net Income Discontinuous | -261 | -287 | N/A | N/A | N/A |
| Net Income | $-2,118 | $-2,262 | $-1,959 | $-1,895 | $-1,875 |
| EPS Basic Total Ops | -0.37 | -0.35 | -0.38 | -0.32 | -0.31 |
| EPS Basic Continuous Ops | -0.33 | -0.31 | -0.28 | -0.32 | -0.31 |
| EPS Basic Discontinuous Ops | -0.04 | -0.04 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.37 | -0.35 | -0.38 | -0.32 | -0.31 |
| EPS Diluted Continuous Ops | -0.33 | -0.31 | -0.28 | -0.32 | -0.31 |
| EPS Diluted Discontinuous Ops | -0.04 | -0.04 | N/A | N/A | N/A |
| EBITDA(a) | $-1,765 | $-1,883 | $-1,755 | $-1,838 | $-1,819 |